MedCap AB

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0009160872
SEK
533.00
5 (0.95%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
606.30
556.60
591.00
501.50
521.70
493.80
474.20
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
606.30
556.60
591.00
501.50
521.70
493.80
474.20
Raw Material Cost
513.50
477.40
511.30
430.10
442.80
424.60
424.20
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
155.50
146.40
151.10
125.60
136.30
129.70
126.50
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
13.50
13.40
14.30
7.60
6.90
4.60
4.80
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
-16.90
-15.98
-16.54
-13.32
-14.32
-13.43
-13.13
Total Expenditure (Excl Depreciation)
513.50
477.40
511.30
430.10
442.80
424.60
424.20
Operating Profit (PBDIT) excl Other Income
92.8
79.2
79.7
71.39999999999999
78.89999999999999
69.2
50
Other Income
10.50
5.00
19.30
4.60
2.50
4.70
8.40
Operating Profit (PBDIT)
148.80
128.30
150.40
111.40
115.50
106.30
88.30
Interest
13.50
13.40
14.30
7.60
6.90
4.60
4.80
Exceptional Items
0.00
0.00
0.00
0.00
-4.00
-3.80
-0.80
Gross Profit (PBDT)
92.80
79.20
79.70
71.40
78.90
69.20
50.00
Depreciation
45.50
44.10
51.40
35.40
34.10
32.40
29.90
Profit Before Tax
89.80
70.80
84.70
68.50
70.40
65.40
52.80
Tax
20.70
14.90
19.60
17.30
16.70
14.70
10.10
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
69.10
55.90
64.60
51.20
53.60
50.50
41.50
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
69.10
55.90
64.60
51.20
53.60
50.50
41.50
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
-0.20
0.50
0.10
0.10
0.20
1.20
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
69.10
55.70
65.10
51.30
53.70
50.70
42.70
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.4
0.4
0.4
0.4
0.4
0.4
0.4
Reserves
1,586.10
1,525.60
1,452.10
1,399.60
1,356.40
1,306.30
1,282.00
Earnings per share (EPS)
4.61
3.72
4.31
3.41
3.57
3.37
2.8
Diluted Earnings per share
4.61
3.72
4.31
3.41
3.57
3.37
2.8
Operating Profit Margin (Excl OI)
15.31%
14.23%
13.49%
14.24%
15.12%
14.01%
10.54%
Gross Profit Margin
22.32%
20.64%
23.03%
20.72%
20.03%
19.81%
17.44%
PAT Margin
11.4%
10.04%
10.93%
10.21%
10.27%
10.23%
8.75%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2026 is 16.22% vs 13.98% in Jun 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2026 is 28.68% vs -5.95% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2026 is 22.39% vs 20.86% in Jun 2025

stock-summary

Interest

YoY Growth in quarter ended Jun 2026 is 95.65% vs 18.97% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025

Compare Quarterly Results Of MedCap AB With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(SEK)
Change(%)
Net Sales
606.30
235.48
370.82
157.47%
Other Operating Income
0.00
0.00
0.00
Total Operating income
606.30
235.48
370.82
157.47%
Raw Material Cost
513.50
99.87
413.63
414.17%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
155.50
0.00
155.50
Power Cost
0
0
0.00
Manufacturing Expenses
13.50
1.24
12.26
988.71%
Selling and Distribution Expenses
0.00
55.73
-55.73
-100.00%
Other Expenses
-16.90
4.90
-21.80
-444.90%
Total Expenditure (Excl Depreciation)
513.50
205.86
307.64
149.44%
Operating Profit (PBDIT) excl Other Income
92.80
29.62
63.18
213.30%
Other Income
10.50
-6.75
17.25
255.56%
Operating Profit (PBDIT)
148.80
43.03
105.77
245.81%
Interest
13.50
1.24
12.26
988.71%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
92.80
135.62
-42.82
-31.57%
Depreciation
45.50
20.16
25.34
125.69%
Profit Before Tax
89.80
21.63
68.17
315.16%
Tax
20.70
3.00
17.70
590.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
69.10
18.63
50.47
270.91%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
69.10
18.63
50.47
270.91%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
69.10
18.63
50.47
270.91%
Equity Capital
0
0
0.00
Face Value
0.40
0.05
0.00
Reserves
1,586.10
4,415.51
-2,829.41
-64.08%
Earnings per share (EPS)
4.61
0.37
4.24
1,145.95%
Diluted Earnings per share
4.61
0.37
4.24
1,145.95%
Operating Profit Margin (Excl OI)
15.31%
12.58%
0.00
2.73%
Gross Profit Margin
22.32%
17.75%
0.00
4.57%
PAT Margin
11.40%
7.91%
0.00
3.49%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 60.63 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 8.93% vs -5.82% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 16.22% vs 13.98% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 6.91 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 24.06% vs -14.44% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 28.68% vs -5.95% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 13.83 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 12.17% vs -5.95% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 22.39% vs 20.86% in Jun 2025

Quarterly - Interest
Interest 1.35 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 0.75% vs -6.29% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 95.65% vs 18.97% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 15.31%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025